Literature DB >> 30093395

A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms.

Raquel Vinhas1, Alexandra Lourenço2, Susana Santos2, Patrícia Ribeiro2, Madalena Silva2, Aida Botelho de Sousa2, Pedro V Baptista3, Alexandra R Fernandes3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30093395      PMCID： PMC6278977          DOI： 10.3324/haematol.2018.192534

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Double Philadelphia-chromosome: a resistance factor on the imatinib mesylate therapy for chronic myeloid leukemia.

Authors:  L Otero; M H Ornellas; J Dobbin; T de Souza Fernandez
Journal:  Int J Lab Hematol       Date:  2008-08       Impact factor: 2.877

2.  CML with e6a2 BCR-ABL1 transcript: an aggressive entity?

Authors:  Karolien Anne Beel; Jan Lemmens; Hilde Vranckx; Johan Maertens; Peter Vandenberghe
Journal:  Ann Hematol       Date:  2011-02-08       Impact factor: 3.673

3.  Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy.

Authors:  Peter Rohon; Martina Divoka; Lenka Calabkova; Renata Mojzikova; Beata Katrincsakova; Zuzana Rusinakova; Anna Lapcikova; Ludek Raida; Edgar Faber; Marie Jarosova; Vladimir Divoky; Karel Indrak
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2011-06       Impact factor: 1.245

4.  Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience.

Authors:  Hagop Kantarjian; Susan O'Brien; Elias Jabbour; Guillermo Garcia-Manero; Alfonso Quintas-Cardama; Jenny Shan; Mary Beth Rios; Farhad Ravandi; Stefan Faderl; Tapan Kadia; Gautam Borthakur; Xuelin Huang; Richard Champlin; Moshe Talpaz; Jorge Cortes
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

Review 5.  Current trends in molecular diagnostics of chronic myeloid leukemia.

Authors:  Raquel Vinhas; Milton Cordeiro; Pedro Pedrosa; Alexandra R Fernandes; Pedro V Baptista
Journal:  Leuk Lymphoma       Date:  2016-12-06

6.  e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?

Authors:  Simona Colla; Gabriella Sammarelli; Simone Voltolini; Monica Crugnola; Paola Sebastio; Nicola Giuliani
Journal:  Haematologica       Date:  2004-05       Impact factor: 9.941

7.  Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.

Authors:  Dushyant Verma; Hagop M Kantarjian; Dan Jones; Rajyalakshmi Luthra; Gautam Borthakur; Srdan Verstovsek; Mary Beth Rios; Jorge Cortes
Journal:  Blood       Date:  2009-06-16       Impact factor: 22.113

8.  Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.

Authors:  Hege K Vefring; Franz X E Gruber; Line Wee; Randi Hovland; Henrik Hjorth-Hansen; Tobias Gedde Dahl; Peter Meyer
Journal:  Acta Haematol       Date:  2009-07-29       Impact factor: 2.195

9.  Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib.

Authors:  Massimo Breccia; Laura Cannella; Daniela Diverio; Paola Streponi; Mauro Nanni; Caterina Stefanizzi; Fiammetta Natalino; Sergio Mecarocci; Giuliana Alimena
Journal:  Leuk Res       Date:  2007-08-03       Impact factor: 3.156

10.  Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts.

Authors:  Stephen E Langabeer; Mireille Crampe; Johanna Kelly; Kamal Fadalla; Gerard Connaghan; Eibhlin Conneally
Journal:  Leuk Res       Date:  2010-03-25       Impact factor: 3.156
View more
  4 in total

1.  Double Philadelphia Chromosomes- A Rare, Yet an Important Cytogenetic Phenomenon of Prognostic Significance in De Novo Acute Lymphoblastic Leukemia.

Authors:  Shanthala Siddappa; Syed Adil Hassan; Kavitha B Lingappa; L K Rajeev; M Padma; Lokanatha Dasappa
Journal:  Indian J Hematol Blood Transfus       Date:  2022-04-16       Impact factor: 0.915

2.  A prognostic approach on a case of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia with monosomy-7.

Authors:  Hanaa Skhoun; Mohammed Khattab; Aziza Belkhayat; Zahra Takki Chebihi; Nadia Dakka; Jamila El Baghdadi
Journal:  Clin Case Rep       Date:  2021-12-26

Review 3.  Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?

Authors:  Bilal Abdulmawjood; Beatriz Costa; Catarina Roma-Rodrigues; Pedro V Baptista; Alexandra R Fernandes
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

4.  Chronic Myelogenous Leukemia with Double Philadelphia Chromosome and Coexpression of p210 and p190 Fusion Transcripts.

Authors:  Samara Silveira da Cruz; Aline Damasceno Seabra; Lais Helena Rescinho Macambira; Débora Monteiro Carneiro; Patrícia Ferreira Nunes; Thais Brilhante Pontes; Fernando Augusto Rodrigues Mello-Junior; Lucyana Barbosa Cardoso Leão; Fernanda de Nazaré Cardoso Dos Santos Cordeiro; Thiago Xavier Carneiro; Caroline Aquino Moreira-Nunes; Rommel Mario Rodríguez Burbano
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.096
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.